THERAPEUTIC EFFICACY OF ZINC OXIDE NANOPARTICLES IN DIABETIC RATS
DOI:
https://doi.org/10.26873/SVR-756-2019Abstract
This study attempted to scrutinize the potential efficacy of zinc oxide nanoparticles (ZnONPs) and the standard oral hypoglycemic drug glibenclamide in streptozotocin (STZ) -nicotinamide induced diabetic rats. Forty male Wistar rats were divided into four equal groups. Group 1 rats received saline orally and considered as a control group. Other groups were experimentally exposed to diabetes via intraperitoneal injection of STZ and group 2 was left as diabetic non-treated. Group 3 was orally administrated with ZnONPs at a low dose (1mg/kg), and group 4 orally received glibenclamide (600 µg/kg) for 30 days (duration of the experiment). Blood glucose, insulin levels, lipogram profile and pancreatic antioxidant status were improved following ZnONPs or glibenclamide administration as compared to the diabetic group. Moreover, histopathological examination revealed a better outcome in the ZnONPs and glibenclamide treated groups. Although oral treatment of ZnONPs at a low dose 1mg/kg body weight for 30 consecutive days had antidiabetic effect, this effect was less superior to glibenclamide. Therefore, further studies regarding increasing the dose of ZnONPs would be encouraging to get better anti diabetic effect.
Key words: Zinc oxide nanoparticles; antioxidant; diabetes; glibenclamide
References
Njolstad PR, Sagen JV, Bjorkhaug L, Odili S, Shehadeh N, Bakry D, Sarici SU, Alpay F, Molnes J, Molven A, Sovik O, Matschinsky FM. Permanent neonatal diabetes caused by gluco-kinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 2003; 52 (11): 2854–60.
Wolfgang M. Zinc in pancreatic islet biol-ogy, insulin sensitivity, and diabetes. Prev. Nutr. Food Sci. 2017; 22 (1): 1–8.
Masaki H, Ochiai Y, Okano Y, Yagami A, Akamatsu H, Matsunaga K, Sakurai H, Suzuki KJ. A zinc (II) - glycine complex is an effective inducer of metallothionein and removes oxida-tive stress. Dermatol. Sci. 2007; 45: 73–5.
Huang SH, Seet RC, Lee CY, Lim EC, Quek AM, Looi WF, Long LH, Halliwell B. Oral zinc supplementation does not improve oxida-tive stress or vascular function in patients with type 2 diabetes with normal zinc levels, Athero-sclerosis 2011; 219: 231–9.
Meyer JA, Spence DM. A perspective on the role of metals in diabetes: past ï¬ndings and possible future directions, Metallomics 2009; 1: 32–41.
Zak AK, Razali R, Majiid WH, Darroudi M. Synthesis and characterization of an arrow size distribution of zinc oxide nanoparticles. Int. J. Nanomed. 2011; 6: 1399-1403.
Chaudhuny K, Kumer V, Kandasamy J, Roy CS. Regenerative nano-medicine: current perspectives and future directions. Int. J. Na-nomed. 2014; 9: 4153–67.
Talylor E, Webster TJ. Reducing infec-tions through nanotechnology and nanoparti-cles, Int. J. Nanomed. 2011; 6: 1463–73.
Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxida-tive stress paradigm. Nano Lett. 2006; 6: 1794–807.
Nel AE, Mädler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. Understanding biophysicochemical interactions at the nano–bio interface Nat. Mater. 2009; 8: 543–57.
Shirgholami M, Nazari A, Mirjalili M. Statistical optimization of self – cleaning tech-nology and color reduction in wool fabric by nano zinc oxide and eco-friendly cross- linker. Clean Technol. Environ. Policy 2015; 17 (4): 905–19.
Gojova A, Guo BR,Kota RS, Rutledge JC, Kennedy IM, and Barak AI. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ. Health Pro. 2007; 115: 403–9.
Tsou TC, Yeh SC, Tsai FY, Lin HJ, Cheng TJ, Chao HR, Tai LA. Zinc oxide parti-cles induce inflammatory responses in vascular endothelial cells via NF-κB signaling. J. Haz-ard. Mater. 2010; 183 (1-3): 182–8.
Umrani RD, Paknikar KM. Zinc oxide nanoparticles show antidiabetic activity in strep-tozotocin-induced Type 1 and 2 diabetic rats. Nano medicine (Lond). 2014; 9 (1): 89–104.
Hussein MM, Ali HA, Saadeldin IM, Ahmed MM. Querectin Alleviates Zinc Oxide Nanoreprotoxicity in Male Albino Rats. J Bio-chem Mol Toxicol. 2016; 30(10):489–96.
Rydberg T, Jönsson A, Karlsson MO, Melander A. Concentration-effect relations of glibenclamide and its active metabolites in man: modeling of pharmacokinetics and Pharmaco-dynamics. Br. J. Clin. Pharmacol. 1997; 43: 373–81.
Asri-Rezaei S, Dalir-Naghadeh B, Naz-arizadeh A, Noori-Sabzikar Z. Comparative study of cardio-protective effects of zinc oxide nanoparticles and zinc sulfate in streptozotocin-induced diabetic rats. J. Trace. Elem. Med. Biol. 2017; 42: 129–41.
Kamel MA. Protective effects of marjo-ram oil (Organiam majorana L,) on anti-oxidant enzymes in experimental diabetic rats. Assuit Vet. Med. J. 2014; 60 (140): 68–74.
Sithole HL. A review of the use of strep-tozotocin (STZ) in the induction of diabetes in rats and subsequent ocular tissue changes. Afr. Vision Eye Health 2009; 68 (2): 82–8.
Trinder P. Enzymatic determination of glucose. Ann. Clin. Biochem. 1969; 6: 24.
Fletcher MJ. A colorimetric method for estimating serum triglycerides. Clin. Chim. Acta. 1968; 22: 393–7.
Finley PR, Schifman RB, Williams RJ, Lichti DA. Cholesterol in high-density Lipo-protein: use of Mg2+/dextran sulfate in its en-zymatic measurement. Clin. Chem. 1978; 24: 931–3.
Gazi I, Tsimihodimos V, Filippatos TD, Saougos VG, Bairaktari ET, Tselepis AD, Elisaf M. LDL cholesterol estimation in patients with the metabolic syndrome. Lipids Health Dis. 2006; 5: 8.
Friedwaid WT, Levy RI, Fedreicson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499–506.
Abdelhady, D.H., El-Magd, M.A., Elbi-aly, Z.I., Saleh, A.A., 2017. Bromuconazole-induced hepatotoxicity is accompanied by up-regulation of PXR/CYP3A1 and downregulation of CAR/CYP2B1 gene expression. Toxicol Mech Methods 27, 544–50.
Aebi H. Catalase, In: Bergmeryer H.U. and Ulrich H. "Methods of Enzymatic Analysis" 2nd ed., Verlag: Chemic, Weinhein, New York, 1974; 673.
McCord JM, Fridovich I. Superoxide dismutase. An enzymatic function for eryth-rocuprein (hemocuprein). J. Biol. Chem. 1969; 244 (22): 6049–55.
Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondial-dehyde as biomarker for oxidative stress. Ref-erence interval and effects of lifestyle factors. Clin. Chem. 1997; 43 (7): 1209–14.
Ricordi C, Rastellini C. Methods in pan-creatic islets separation. In: Ricordi C. Editor. Methods in Cell Transplantation. Austin, TX: R.G. Landes 1995; 433–8.
Wild SG, Green A, Sicrec R, King H. "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030", Diabe-tes care 2004; 27 (5): 1047–53.
Ukperoro JU, Offiah N, Idris T, Awogoke D. Antioxidant effect of zinc, seleni-um and their combination on the liver and kid-ney of alloxan-induced diabetes in rats. Med. J. Nutr. Metab. 2010; 3 (1): 25–30.
Moustafa SA. Zinc might protect oxida-tive changes in the retina and pancreas at the early stage of diabetic rats. Toxicol. Appl. Pharmacol. 2004; 201: 149–55.
Gupta S, Kataria M, Gupta PK, Mugan-dan S, Yash RC. Protective role of extracts of neem seeds indiabetes caused by streptozotocin in rats. J. Ethnopharmacol. 2004; 90: 185–9.
Yamamoto Y, Ford RC, Barber J. Rela-tionship between thylakoid membrane fluidity and the functioning of pea chloroplasts: Effect of cholesteryl hemisuccinate. Plant Physiol. 1981; 67:
–72.
Rinku DU, Paknikar MK. Zinc oxide nanoparticles show antidiabetic activity in strep-tozotocin-induced Type 1 and 2 diabetic rats. Nanomedicine 2013; 9(1): 89–104.
Raju SM, Raju B. Illustrated Medical Bi-ochemistry. 2010; 2nd Edition, Jaypee Brothers Medical Publishers Ltd., New Delhi.
Manschot SM, biessels GJ, Rutten GE, Kessels RC, Gispen WH, Kappelle LJ. Peripher-al and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. J. Neurol Sci. 2008; 264 (1-2): 157–62.
Ahrén B. Type 2 diabetes, insulin secre-tion and beta-cell mass. Curr. Mol. Med. 2005; 5 (3): 275–86.
Elahi MM, Kong YX, Matata BM. Oxida-tive stress as a mediator of cardiovascular dis-ease. Oxid. Med. cell. long. 2009; 2: 259–69.
Huang J, Das SK, Jha P, Alzoughi W, Schauor S, Claudel T, Sexal V, Vesely P, Birner Gruenberger R, Krutky D, Michael T, Gerald H. The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid me-tabolism. Biochim. Biophys. Acta. 2013; 1831(10): 1555–65.
Daisy MM, Rashmi V, Akila G, Gun-asekaran S. Effect of streptozotocin on the ul-trastructure of rat pancreatic islets. Microsc. Res. Tech. 2004; 63 (5): 274–81.
